Status:
RECRUITING
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Peripheral Vascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to suppo...
Detailed Description
A global prospective, non-randomized, open-label, multi-center Registry to collect Real-World Data, including health economic data, to support the use of commercially available drug-eluting BSC device...
Eligibility Criteria
Inclusion
- Patients 18 years and older
- Written informed consent (patient data release-form)
- Use of any commercially available Boston Scientific drug-eluting device marketed for treatment of lesions in the peripheral vasculature and specified in the Registry Enrollment Guide
Exclusion
- Life expectancy of \<1 year
Key Trial Info
Start Date :
March 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04674969
Start Date
March 29 2021
End Date
January 1 2028
Last Update
December 24 2025
Active Locations (79)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Bernard's Medical Center
Jonesboro, Arkansas, United States, 72401
2
PIH Health Good Samaritan Hospital
Los Angeles, California, United States, 90017
3
Cedars - Sinai Medical Center
Los Angeles, California, United States, 90048
4
Ronald Reagan UCLA Medical Center
Los Angeles, California, United States, 90095